-
PRESS RELEASE: Lighting Science and Global Good to Develop Light-Based Alternatives to Pesticides
Lighting Science Group Corporation and Intellectual Ventures’ Global Good today announced a research agreement to collaborate on the development of next-generation light technologies for pest control.
- Categories
- Health Care
-
Johns Hopkins Researchers Identify Key to Tuberculosis Resistance
The cascade of events leading to bacterial infection and the immune response is mostly understood. However, the molecular mechanisms underlying the immune response to the bacteria that causes tuberculosis have remained a mystery — until now.
- Categories
- Education, Health Care
-
Drought-Stricken São Paulo Battles Dengue Fever Outbreak
Inhabitants of this megacity, suffering through the worst drought in decades, have unwittingly contributed to an outbreak of dengue fever by storing scarce water in open containers.
- Categories
- Education, Health Care
- Region
- Latin America
-
Bengaluru-based Molbio develops India’s first swine flu diagnostic kit
The swine flu flare-up has pushed an indigenous innovation faster into the market, a rare silver lining in an otherwise gloomy story, as India battles the worst outbreak of the virus in the past five years.
- Categories
- Health Care
- Region
- South Asia
-
Pakistan wastes $3.7 million worth of donated vaccine, official says
Pakistan has wasted $3.7 million worth of vaccines donated to protect children from deadly diseases because officials failed to store them properly, a senior health official told Reuters on Monday.
- Categories
- Health Care
-
A Research Agenda for HIV Survivors
Chronic disease among HIV positive people has been overlooked, say K. M. Venkat Narayan and Sten Vermund. Over 35 million people worldwide are living with HIV. Massive global efforts and investments to deliver combination antiretroviral therapy (ART) have transformed a fatal infectious disease into a chronic, treatable disease.
- Categories
- Health Care
-
Big Pharma, NGO Square the Circle on Access to Vaccines
One would expect a multinational pharmaceutical group and a leading humanitarian NGO to hold radically opposed views on access to vaccines.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
The Upside of Ebola May Be Vaccines
They don’t have the name recognition of Ebola, but lymphatic filariasis and schistosomiasis are killer viruses in developing countries. Big killers. Indeed, combined with other illnesses like malaria and pneumonia, infectious diseases account for 1 in 7 deaths worldwide. But good luck trying to convince drug companies to put resources and funds into developing vaccines for most of them: Diseases in poor countries don’t make for lucrative markets.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.